Alemnew F Dagnew

5PUBLICATIONS
37CO-AUTHORS
Social determinants of healthInnate immunityEnvironmental epidemiologyEpidemiological methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 08, 2022
End-point definition and trial design to advance tuberculosis vaccine development.

Alberto L Garcia-Basteiro, Richard G White, Dereck Tait

|Aug 18, 2021
Adjuvanted recombinant zoster vaccine in adult autologous stem cell transplant recipients: polyfunctional immune responses and lessons for clinical practice.

Edward A Stadtmauer, Keith M Sullivan, Mohamed El Idrissi

|Jun 30, 2021
Immune responses to the adjuvanted recombinant zoster vaccine in immunocompromised adults: a comprehensive overview.

Alemnew F Dagnew, Peter Vink, Mamadou Drame

|Feb 28, 2020
The Adjuvanted Recombinant Zoster Vaccine in Adults Aged ≥65 Years Previously Vaccinated With a Live-Attenuated Herpes Zoster Vaccine.

Alemnew F Dagnew, Nicola P Klein, Caroline Hervé

|Jun 20, 2019
Medical conditions at enrollment do not impact efficacy and safety of the adjuvanted recombinant zoster vaccine: a pooled post-hoc analysis of two parallel randomized trials.

Lidia Oostvogels, Thomas C Heineman, Robert W Johnson

Pageof 1

Frequent Collaborators

2 joint publications

Lidia Oostvogels

2 joint publications

Thomas C Heineman

2 joint publications

Anne E Schuind

2 joint publications

Bruno Salaun